GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Price-to-Operating-Cash-Flow

Kadimastem (XTAE:KDST) Price-to-Operating-Cash-Flow : (As of Oct. 31, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Price-to-Operating-Cash-Flow?

As of today (2024-10-31), Kadimastem's share price is ₪9.121. Kadimastem's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-1.64. Hence, Kadimastem's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Kadimastem's Price-to-Operating-Cash-Flow or its related term are showing as below:

XTAE:KDST's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 26.97
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Kadimastem's Cash Flow from Operations per share for the six months ended in Jun. 2024 was ₪-0.74. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-1.64.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 43.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 38.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 23.60% per year.

During the past 11 years, Kadimastem's highest 3-Year average Operating Cash Flow per Share Growth Rate was 43.40% per year. The lowest was -42.60% per year. And the median was 34.20% per year.


Kadimastem Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Kadimastem's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadimastem Price-to-Operating-Cash-Flow Chart

Kadimastem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kadimastem Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Kadimastem's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Kadimastem's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kadimastem's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kadimastem's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Kadimastem's Price-to-Operating-Cash-Flow falls into.



Kadimastem Price-to-Operating-Cash-Flow Calculation

Kadimastem's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=9.121/-1.644
=

Kadimastem's Share Price of today is ₪9.121.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kadimastem's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-1.64.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Kadimastem Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Kadimastem's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Kadimastem Business Description

Industry
Traded in Other Exchanges
N/A
Address
Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem Headlines

No Headlines